We express our disappointment regarding the ruling of the European Court of Justice classifying plants obtained by recent techniques such as CRISPR/Cas9-mediated genome editing as genetically modified organisms (GMOs), implying the requirement for extensive pre-market risk evaluations laid down in EU Directive 2001/18/EC.